EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Ethanol infusion of the vein of marshall-based strategies for persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials

Harroop Bola iD, Thalia Melamed iD, Mohamed Allaf iD, Joshua J Hon iD, Gayathri Giritharan iD, Amar Rai iD, Kiran Haresh Kumar Patel, Fu Siong Ng iD

Europace · 30.03.2026 · 28 (4)

DOI: 10.1093/europace/euag069 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Europace, online erschienen am 02.04.2026. Verfasst von Harroop Bola und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Imperial College London, South Kensington Campus London, London SW7 2AZ, UK. Hauptthemen laut MEDLINE: Atrial Fibrillation, Ethanol, Pulmonary Veins, Catheter Ablation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Pulmonary vein isolation (PVI) alone achieves modest arrhythmia freedom in persistent atrial fibrillation (PeAF). Ethanol infusion of the vein of Marshall (EIVOM) overcomes heat-sink effects, facilitating mitral isthmus (MI) block, and may represent an effective adjunctive ablation strategy. We aimed to quantify the efficacy and safety of EIVOM through a meta-analysis of randomized controlled trials (RCTs). Methods and results Systematic review of MEDLINE, Web of Science, and PubMed identified 5 RCTs enrolling 1179 patients (602 EIVOM, 577 control). The primary endpoint was 12-month freedom from any atrial arrhythmia. Random-effects models generated risk ratios (RRs) with 95% confidence intervals (CI). Time-to-event data were pooled using a generic inverse-variance approach to derive hazard ratios (HR). EIVOM-based strategies improved freedom from any arrhythmia (RR 1.16, 95% CI 1.04–1.29; P < 0.001; number needed to treat (NNT) = 10) and from atrial fibrillation (RR 1.11, 95% CI 1.05–1.18; P < 0.001; NNT = 13). Time-to-event analysis demonstrated a sustained reduction in recurrence hazard (HR 0.72, 95% CI 0.64–0.81; P = 0.003; I2 = 0%). Repeat ablation was reduced (RR 0.61; P = 0.009). Fluoroscopy time increased (+9.08 min; P = 0.007), while major complications were comparable (2.5% vs. 2.8%; P = 0.47). Trial sequential analysis confirmed that the cumulative Z-curve crossed the monitoring boundary for benefit for the primary endpoint, indicating that the available evidence is sufficient.

Conclusion

In PeAF, EIVOM-based ablation strategies significantly improve 12-month arrhythmia-free survival and reduce repeat procedures without increasing major adverse events. However, the observed benefit reflects composite ablation sets rather than ethanol infusion in isolation, and the predominance of high-volume expert centres may limit generalizability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationEthanolPulmonary VeinsCatheter AblationAblation TechniquesHumansRandomized Controlled Trials as TopicTreatment OutcomeRecurrenceRisk FactorsTime FactorsProgression-Free SurvivalInfusions, IntravenousDisease-Free Survival

Stichwörter der Autor:innen

Atrial fibrillationCatheter ablationEthanol infusionPersistent atrial fibrillationSubstrate modificationVein of Marshall

Substanzen

Ethanol

Autor:innen und Institutionen

  • Faculty of Medicine, Imperial College London, South Kensington Campus London, London SW7 2AZ, UK.
  • London Northwest Healthcare NHS Trust, Department of Integrated Medicine, Northwick Park Hospital, London HA1 3UJ, UK.
  • Chelsea and Westminster Hospital NHS Foundation Trust, Department of Internal Medicine, London, UK.
  • Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • National Heart and Lung Institute, Imperial College London, London, UK.
  • Department of Cardiology, Imperial College Healthcare NHS Trust, London, UK.

ORCID-Profile: Harroop Bola, Thalia Melamed, Mohamed Allaf, Joshua J Hon, Gayathri Giritharan, Amar Rai, Fu Siong Ng

Zitieren

APA

Bola, H., Melamed, T., Allaf, M., Hon, J. J., Giritharan, G., Rai, A., Patel, K. H. K., & Ng, F. S. (2026). Ethanol infusion of the vein of marshall-based strategies for persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials. Europace, 28(4). https://doi.org/10.1093/europace/euag069

Vancouver

Bola H, Melamed T, Allaf M, Hon JJ, Giritharan G, Rai A, et al. Ethanol infusion of the vein of marshall-based strategies for persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials. Europace. 2026;28(4). doi:10.1093/europace/euag069

BibTeX
@article{Bola2026,
  author = {Bola, Harroop and Melamed, Thalia and Allaf, Mohamed and Hon, Joshua J and Giritharan, Gayathri and Rai, Amar and Patel, Kiran Haresh Kumar and Ng, Fu Siong},
  title = {Ethanol infusion of the vein of marshall-based strategies for persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials},
  journal = {Europace},
  year = {2026},
  volume = {28},
  number = {4},
  doi = {10.1093/europace/euag069}
}
Kostenlos starten →